EP3924375A4 - UNIVERSAL DONOR STEM CELLS AND RELATED METHODS - Google Patents

UNIVERSAL DONOR STEM CELLS AND RELATED METHODS Download PDF

Info

Publication number
EP3924375A4
EP3924375A4 EP20755906.3A EP20755906A EP3924375A4 EP 3924375 A4 EP3924375 A4 EP 3924375A4 EP 20755906 A EP20755906 A EP 20755906A EP 3924375 A4 EP3924375 A4 EP 3924375A4
Authority
EP
European Patent Office
Prior art keywords
stem cells
related methods
universal donor
donor stem
universal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP20755906.3A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3924375A2 (en
Inventor
Torsten B. Meissner
Leonardo M.R. FERREIRA
Jack L. Strominger
Chad A. COWAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of EP3924375A2 publication Critical patent/EP3924375A2/en
Publication of EP3924375A4 publication Critical patent/EP3924375A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1114—T cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP20755906.3A 2019-02-15 2020-02-16 UNIVERSAL DONOR STEM CELLS AND RELATED METHODS Withdrawn EP3924375A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201916277913A 2019-02-15 2019-02-15
US201916596697A 2019-10-08 2019-10-08
PCT/US2020/018467 WO2020168317A2 (en) 2019-02-15 2020-02-16 Universal donor stem cells and related methods

Publications (2)

Publication Number Publication Date
EP3924375A2 EP3924375A2 (en) 2021-12-22
EP3924375A4 true EP3924375A4 (en) 2023-03-22

Family

ID=72045137

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20755906.3A Withdrawn EP3924375A4 (en) 2019-02-15 2020-02-16 UNIVERSAL DONOR STEM CELLS AND RELATED METHODS

Country Status (11)

Country Link
EP (1) EP3924375A4 (es)
JP (1) JP2022526218A (es)
KR (1) KR20210128440A (es)
CN (1) CN113906048A (es)
AU (1) AU2020223192A1 (es)
BR (1) BR112021016178A2 (es)
CA (1) CA3130398A1 (es)
IL (1) IL285619A (es)
MX (1) MX2021009842A (es)
SG (1) SG11202108891QA (es)
WO (1) WO2020168317A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021231712A1 (en) * 2020-05-15 2021-11-18 Rxcell Inc. Hypoimmunogenic cells and uses thereof in immune responses
CN114276995A (zh) * 2020-09-28 2022-04-05 未来智人再生医学研究院(广州)有限公司 一种表达ctla-4阻遏分子的多能干细胞及其衍生物
CN114525257A (zh) * 2020-10-30 2022-05-24 未来智人再生医学研究院(广州)有限公司 一种表达Tim-3阻断物的多能干细胞或其衍生物及应用
CN114525256A (zh) * 2020-10-30 2022-05-24 未来智人再生医学研究院(广州)有限公司 一种表达Siglec-15阻断物的多能干细胞或其衍生物及应用
CN114457021A (zh) * 2020-10-30 2022-05-10 未来智人再生医学研究院(广州)有限公司 一种表达cd47抗体的多能干细胞及其衍生物与应用
EP4251741A1 (en) 2020-11-30 2023-10-04 CRISPR Therapeutics AG Gene-edited natural killer cells
CR20230303A (es) * 2020-12-11 2023-09-01 Intellia Therapeutics Inc Composiciones y métodos para reducir el mhc de clase ii en una célula
AU2021410751A1 (en) * 2020-12-23 2023-07-13 Intellia Therapeutics, Inc. Compositions and methods for genetically modifying ciita in a cell
MX2023006207A (es) 2020-12-31 2023-08-09 Sana Biotechnology Inc Métodos y composiciones para modular la actividad de linfocitos t con receptores de antígenos quiméricos (t-car).
AU2022283291A1 (en) 2021-05-27 2023-11-02 Sana Biotechnology, Inc. Hypoimmunogenic cells comprising engineered hla-e or hla-g
MX2024001443A (es) 2021-08-11 2024-05-15 Sana Biotechnology Inc Sistemas inducibles para alterar la expresión génica en células hipoinmunógenas.
KR20240137574A (ko) 2021-12-23 2024-09-20 사나 바이오테크놀로지, 인크. 자가면역 질환 치료를 위한 키메라 항원 수용체[chimeric antigen receptor, car] t 세포 및 관련 방법
WO2023154578A1 (en) 2022-02-14 2023-08-17 Sana Biotechnology, Inc. Methods of treating patients exhibiting a prior failed therapy with hypoimmunogenic cells
WO2023191063A1 (ja) * 2022-04-01 2023-10-05 株式会社Logomix 遺伝子工学、細胞工学、および細胞医薬に適した細胞およびその製造方法
WO2024003349A1 (en) 2022-07-01 2024-01-04 Novo Nordisk A/S Enhancing neuronal differentiation of ventral midbrain neural progenitor cells
CN118406681A (zh) * 2023-01-30 2024-07-30 南京北恒生物科技有限公司 用于同种异体移植的组合物及方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017079673A1 (en) * 2015-11-04 2017-05-11 Fate Therapeutics, Inc. Genomic engineering of pluripotent cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016261600B2 (en) * 2015-05-08 2021-09-23 President And Fellows Of Harvard College Universal donor stem cells and related methods
JP2020505025A (ja) * 2017-01-13 2020-02-20 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 免疫工学的な改変をした多能性細胞

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017079673A1 (en) * 2015-11-04 2017-05-11 Fate Therapeutics, Inc. Genomic engineering of pluripotent cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XIAO HAN ET AL: "Generation of hypoimmunogenic human pluripotent stem cells", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 116, no. 21, 30 April 2019 (2019-04-30), pages 10441 - 10446, XP055640699, ISSN: 0027-8424, DOI: 10.1073/pnas.1902566116 *

Also Published As

Publication number Publication date
CN113906048A (zh) 2022-01-07
WO2020168317A8 (en) 2021-02-25
SG11202108891QA (en) 2021-09-29
WO2020168317A2 (en) 2020-08-20
BR112021016178A2 (pt) 2021-11-03
CA3130398A1 (en) 2020-08-20
EP3924375A2 (en) 2021-12-22
KR20210128440A (ko) 2021-10-26
MX2021009842A (es) 2021-12-10
WO2020168317A3 (en) 2020-10-29
IL285619A (en) 2021-09-30
AU2020223192A1 (en) 2021-09-09
JP2022526218A (ja) 2022-05-24

Similar Documents

Publication Publication Date Title
EP3924375A4 (en) UNIVERSAL DONOR STEM CELLS AND RELATED METHODS
AU2021221859A1 (en) Universal donor stem cells and related methods
EP3652304A4 (en) UNIVERSAL DONOR CELLS AND RELATED PROCESSES
EP3875469A4 (en) NEW CRISPR/CAS12F ENZYME AND SYSTEM
EP3882345A4 (en) CRISPR-CAS12J ENZYME AND SYSTEM
EP3699268A4 (en) UNIVERSAL CAR-T CELL, ITS PREPARATION PROCESS AND ITS APPLICATION
EP3854877A4 (en) MODIFIED T LYMPHOCYTE, METHOD FOR PREPARATION AND USE
EP3966316A4 (en) MODIFIED PLURIPOTENT CELLS
EP3423564A4 (en) MICROGLIAL CELLS DERIVED FROM PLURIPOTENT STEM CELLS AND METHODS OF PREPARATION AND USE THEREOF
EP4083067A4 (en) CD7-CAR-T CELL, ITS PREPARATION AND ITS USE
EP3845654A4 (en) CAR-EXPRESSING T CELLS AND CAR-EXPRESSION VECTOR
EP3615082A4 (en) COMPOSITIONS AND PROCEDURES FOR ENZYMIMMOBILIZATION
EP3843774A4 (en) HEART CELL REPROGRAMMING WITH MYOCARDIN AND ASCL1
EP3911897A4 (en) VALVE SYSTEM AND PROCESS
EP3336176A4 (en) IMPROVED ANNEXED STRAIN CELLS FROM HORIZONTAL TISSUE, MANUFACTURING METHOD AND USE THEREOF
IL291044A (en) Universal donor cells
IL290504A (en) Universal donor cells
EP3609997A4 (en) MULTIDONOR STEM CELL COMPOSITIONS AND METHOD FOR MANUFACTURING THEM
EP3865571A4 (en) MESENCHYMATOUS STEM CELLS DERIVED FROM THE SYNOVIAL AND THEIR USE
EP3941631A4 (en) ISOLATION OF SINGLE CELLS AND THEIR USES
EP4034172A4 (en) GMO MESENCHYMAL STEM CELLS AND THEIR USES
EP3810756A4 (en) MODIFIED T LYMPHOCYTES AND THEIR USES
EP4099985A4 (en) METHODS AND USE FOR GENETIC MODIFICATION OF ENUCLEATED CELLS
EP4041255A4 (en) MODIFIED STEM CELLS AND THEIR USE
EP3426268A4 (en) PANCREATIC STEM CELLS AND USES THEREOF

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210902

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40065863

Country of ref document: HK

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: C07K0014740000

Ipc: C12N0005073500

A4 Supplementary search report drawn up and despatched

Effective date: 20230220

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/113 20100101ALI20230214BHEP

Ipc: C12N 5/074 20100101ALI20230214BHEP

Ipc: C07K 14/705 20060101ALI20230214BHEP

Ipc: C07K 14/74 20060101ALI20230214BHEP

Ipc: C12N 5/0735 20100101AFI20230214BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230921